Timing-window and therapeutic effects of stem cell transplantation: A meta-analysis

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 11, 2007, Pages 2164-2166

  Yang, Shui Xiang ^a   Xu, G Y ^a   Zhao, N N ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; CORRELATION FUNCTION; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; INFORMATION RETRIEVAL; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 34250358336     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hristov M, Weber C. The therapeutic potential of progenitor cells in ischemic heart disease-Past, present and future. Basic Res Cardiol 2006; 101(1):1-7
2. Cleland JG, Freemantle N, Coletta AP, et al. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-11, SURVIVE, and PROACTIVE. Eur. J Heart Fail 2006;8(1):105-110
3. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary Bone, Marrow Cell Transfer After Myocardial Infarction. Eighteen Months' Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial. Circulation 2006;113 (10):1287-1294
4. Bartunek J, Wijns W, Heyndrickx GR, et al. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Mad 2006;3 Suppl 1:S52-S56
5. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367 (9505):87-88
6. Lunde K, Solheim S, Aakhus S, et al. Autologous stem cell transplantation in acute myocardial infarction. The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 200&,39(3): 150-158
7. Kuethe F, Richartz BM, Sayer HG, et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 2004;97(1):123-127
8. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration, enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004;44(8):1690-1699
9. Chinese source.
10. Brehm M, Strauer BE. Stem cell therapy in postinfarction chronic coronary heart disease. Nat Clin Pract Cardiovasc Med 2006;3 Suppl 1:S101-104
11. Chen SL, Fang WW, Qian J, et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Mad J (Engl) 2004;117 (10):1443-1448
12. Minguell JJ, Erices A.Mesenchymal stem cells and the treatment of cardiac disease.Exp Biol Med (Maywood) 2006;231(l):3949